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Abstract
Pax4 is a member of the Pax (Pax, paired box) family of transcription factors with restricted expression and essential functions in the
developing pancreas. Pax4 de®cient mice do not develop pancreatic beta and delta cells and thus die after birth due to diabetes. In this study
using transgenic mouse technology we report the identi®cation and characterization of a 0.9 kb DNA fragment in the 5 0-region of the gene,
which by itself is able to direct Pax4 expression in the endocrine pancreas, recapitulating the beta-cell-speci®c in vivo expression pattern of
Pax4. The 0.9 kb DNA fragment contains an area spanning 407 base pairs that is highly conserved between human and mouse showing 88%
identity. This promoter region contains sequence motifs that have been shown to be involved in beta-cell-speci®c expression of insulin, Pdx1
and islet amyloid polypeptide (IAPP). In addition, we determined a previously undescribed 5 0intron. q 2001 Elsevier Science Ireland Ltd.
All rights reserved.
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1. Introduction
The mammalian pancreas accomplishes numerous tasks
concerning digestion and glucose homeostasis. Functionally
it can be divided into two parts. The exocrine part synthe-
sizes digestive enzymes and releases them to the duodenum.
The blood sugar level is controlled by the endocrine part of
the organ, whose smallest functional unit is the Islet of
Langerhans. Within the islets four cell types can be found:
alpha, beta, delta and PP cells that produce glucagon, insu-
lin, somatostatin and pancreatic polypeptide, respectively.
These hormones are directly released into the blood stream.
Malfunctions of the endocrine pancreas can seriously
disturb the regulation of the blood sugar level carried out
by these hormones and result in life threatening diseases
such as diabetes.
The molecular mechanisms of pancreas development are
not completely understood. However, several differentiation
and transcription factors have been detected that are crucial
for pancreatic organogenesis and differentiation of cell
types (Slack, 1995; Edlund, 1998; Yamaoka and Itakura,
1999). These include Activin, Shh, Pdx1, Isl1, ngn3,
BETA2/NeuroD, Nkx2.2, Hes1, HNF6, Pax6 and Pax4
(Hebrok et al, 1998; Furukawa et al., 1995; Apelqvist et
al., 1997; Kim et al., 1997; Jonsson et al., 1994; Of®eld et
al., 1996; Ahlgren et al., 1997; Gradwohl et al., 2000; Naya
et al., 1997; Rudnick et al., 1994; Sussel et al., 1998; Jensen
et al., 2000; Jacquemin et al., 2000; St. Onge et al., 1997;
Sosa-Pineda et al., 1997). The Pax genes have been shown
to have decisive in¯uence on the maturation of all endocrine
cell types (reviewed in Mansouri et al., 1999; Dohrmann et
al., 2000). Pax6 de®cient mice lack alpha cells and the
remaining endocrine cells do not form proper islets (St.
Onge et al., 1997). Pax4 turned out to be required for the
differentiation of insulin-producing beta and somatostatin-
producing delta cells. Even though islets can be found in
Pax4 de®cient mice the number of glucagon-producing
alpha cells within the islets appears to be increased and to
replace the missing beta and delta cells (Sosa-Pineda et al.,
1997).
Pancreas development in mice starts at about E 8.5 (E:
embryonic days, days post coitum). Production of insulin
and glucagon can be detected in the earliest precursor cells
(Gittes and Rutter, 1992). Interestingly, even in the Pax4
knock-out mice insulin-producing cells show up in the ®rst
pancreatic precursors (Dohrmann et al., 2000). At E 9.5, all
insulin-containing cells coexpress glucagon, but the percen-
tage of double labelled cells decreases after E 14.5, when
the ®rst somatostatin-expressing cells arise. Until E 18.5 all
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these cell types are not organized and can be found distrib-
uted throughout the exocrine tissue but at the end of gesta-
tion with the ®rst appearing PP cells they gather to form
mature islets (Yamaoka and Itakura, 1999).
Expression of Pax4 during pancreas development is
tightly regulated. Pax4 mRNA is detected in few cells in
the ventral spinal cord and pancreatic bud as early as E 9.5
in mice, but the Pax4 expression is later restricted to
pancreatic beta and delta cells and vanishes soon after
birth (Sosa-Pineda et al., 1997). A maximum level of
expression can be seen at E 15.5 (Dohrmann et al., 2000).
For a better understanding of the mechanism of the
temporally and spatially regulated expression pattern of
Pax4, it is necessary to characterize the regulatory elements.
Although the mouse Pax4 cDNA has been cloned recently
(Matsushita et al., 1998; Inoue et al., 1998; KalousovaÂ et al.,
1999) the genomic structure of the 5 0 end of Pax4 and the
Pax4 promoter has not been characterized in vivo yet. So
far, 10 exons have been described. In this study we identify
and characterize a 0.9 kb Pax4 promoter fragment that
mediates the described Pax4 expression pattern using trans-
genic mice as a model system. Furthermore, we report the
detection of a so far undescribed 5 0intron.
2. Results
2.1. Identi®cation of the functional Pax4 promoter element
A 19 kb genomic DNA clone (from liver DNA of BALB/
c mice, see Walther et al., 1991 for further details) contain-
ing the mouse Pax4 locus was isolated and physically
mapped (Fig. 1). Since most regulatory elements of genes
are known to reside within the 5 0-region of the genomic
sequences (O'Shea-Green®eld and Smale, 1992), the most
upstream 7.8 kb NotI/NheI DNA fragment was ligated in
frame to the lacZ gene (Fig. 2a). We tested this construct for
reporter gene activity in four transgenic mouse lines gener-
ated by microinjection. We analyzed E 10.5 mice and
newborn pancreas for beta galactosidase activity by the x-
gal reaction. Three of four transgenic lines showed reporter
gene activity in the pancreas of E 10.5 mouse embryos (two
of them shown in Fig. 3B,C) and in islets of newborn
pancreas (Fig. 3E,F). As a control, we compared this expres-
sion pattern with that of heterozygous Pax4 knockout mice
generated by homologous recombination (Fig. 3A). In these
mice, most of the Pax4 coding sequences of one allel have
been replaced by the lacZ gene (Sosa-Pineda et al., 1997).
The expression mediated by the 7.8 kb fragment in all
detectable cases showed pancreatic expression like the
expression in the wild type situation (Pax4 1/2). Occasion-
ally, ectopic reporter gene activity most likely due to posi-
tional effects could be seen in the transgenic lines (Fig. 3B).
However, the expression in the pancreas in all cases was
indistinguishable from that of heterozygous Pax4 knock-out
mice and like in the wild type Pax4 expression dynamics
vanished after birth. We therefore conclude that the 7.8 kb
fragment harbors the Pax4 promoter and is able to repro-
duce the in vivo expression pattern of Pax4. This fragment
includes the 5 0 end of the 19 kb genomic clone, the ®rst
exons and also part of the coding sequences of Pax4 (Fig.
2a).
2.2. Delineation of the genomic structure of Pax4
The mouse Pax4 full length cDNA sequence has already
been published (Inoue et al., 1998) and the genomic struc-
ture of the gene has been described (Inoue et al., 1998;
KalousovaÂ et al., 1999). To delineate the genomic structure
of the 5 0region of Pax4 concerning the functional Pax4
promoter element we sequenced the 7.8 kb fragment (gene
bank accession number AF304868) and compared it to the
full length cDNA sequence of Pax4. This revealed the exis-
tence of a previously undescribed intron of 1948 bases. The
transcription start is predicted to be 2211 nucleotides
upstream of the translation start site (Fig. 1). These ®ndings
are consistent with the mouse transcription start site recently
described by Smith et al. (2000). As a consequence, the
ATG is located at position 95 of the second exon. The
®rst exon spans 169 nucleotides of 5 0untranslated DNA
sequence so that the complete 5 0-UTR (UTR, untranslated
region) is predicted to be 264 base pairs (bp) in size.
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Fig. 1. Physical and genomic map of the Pax4 locus showing the existence of an additional intron between exons 1 and 2 and the location of the described 0.9 kb
promoter fragment (P). Exons 1±11 are in blue, the putative transcription start is marked with an arrow. The 0.9 kb promoter region is given in red. Cutting sites
for restriction enzymes: B, BamHI; E, EcoRI; H HindIII; Nh, NheI; S, SmaI; St, StuI.
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Fig. 3. Reporter gene activity in transgenic mouse lines. (A) Control: heterozygous E 10.5 knockout mouse (KO 1 /2) showing lacZ expression in the pancreas
(black arrow). (B,C) Mouse lines transgenic for the 7.8 kb construct (Tg7.8, Fig. 2a). (B) E 10.5 mouse showing reporter gene activity in the pancreas (black
arrow) but also ectopic signals in eye, nose and tail. (C) E 10.5 mouse showing no ectopic signals, but weak pancreatic expression (black arrow). (D) Mouse
line transgenic for the 0.9 kb construct (Tg0.9, Fig. 2e). An E 10.5 mouse showing background staining in the umbilical cord, ectopic expression and expression
in the pancreas (black arrow). Newborn pancreas of mouse lines transgenic for the 7.8 kb element (7.8 Newb., E,F) and the 0.9 kb element (0.9 Newb., G,H) is
shown in the bottom row. Reporter gene expression in islets of newborn pancreas (E,G, black arrows) co-localized with beta cells visualized by detecting
insulin expression using ¯uorescent immunohistochemistry (F,H, white arrows).
Fig. 2. Constructs that were tested in transgenic mice. All of them were tested in transient transgenic mice and gave positive results (1). For the constructs that
have been used to establish mouse lines the ratio of reporter gene expressing lines to the total number of generated transgenic lines is given on the left. In (b)
and (c) `trans' is meaning only transient transgenic mice have been analyzed. Starting from the 19 kb genomic clone (Fig. 1), the constructs were created in a
row from (a) to (e). The enzymes that have been used for creating deletions within the previous construct are shown, respectively. The 407 bp cassette with high
homology to the human sequence is shown as a green box, the putative transcription start is marked with an arrow, exons are in red, the lacZ reporter gene is
outlined in blue. (a) A NotI/NheI fragment representing the mostly 5 0 7.8 kb of the 19 kb genomic clone (Fig. 1) was ligated in frame to the lacZ reporter gene.
It contains the native transcription start and the ®rst three exons. (b±d) Deletions using the enzymes NcoI (b), BalI (c) and AvrII (d) lead to the given constructs.
(e) A 0.9 kb SmaI/NcoI fragment was cloned in front of lacZ.
Absence of the proximal TATA or CAAT boxes or a Sp1
motif indicates a deviation from the classical promoter
structure.
2.3. Homology to human sequences and further delineation
of the Pax4 promoter
We then compared the mouse Pax4 promoter sequence to
the human cosmid clone AC000359 sequence known to
contain the human Pax4 coding region to ®nd evolutionary
conserved sequences. Starting at 2003 nucleotides upstream
of the murine transcription start we identi®ed a 407 bp DNA
cassette showing 88% sequence identity to the homologous
human region (Fig. 4a, red label). To further delineate the
Pax4 promoter and assuming an evolutionary conservation
of important regulatory sequences, we deleted areas
surrounding the conserved region starting from the
previously tested 7.8 kb construct. This was accomplished
by taking advantage of suitable restriction enzymes (Fig. 2).
First, by excising a 2.5 kb NcoI fragment the ®rst exon and
surrounding sequences were deleted (Fig. 2b). Since we
removed the transcription start we expected the reporter
signal to be silenced. Surprisingly, the resulting 5.3 kb frag-
ment of genomic sequence also mediated a Pax4-like
expression pattern in transient transgenic mice (not
shown) revealing the presence of a second putative tran-
scription initiation site. Further deletion constructs were
then created starting from this 5.3 kb construct as shown
in Fig. 2c,d. As occurred with the 7.8 kb fragment, the
transgenic mice generated using these constructs showed a
reporter gene activity that recapitulated the in vivo expres-
sion pattern of Pax4 in the pancreas. We veri®ed this for
both, 3.9 and 2.8 kb constructs analyzing the expression
patterns of the reporter in E 10.5 embryos and newborn
pancreas of transient transgenic mice (3.9 and 2.8) and a
mouse line (2.8, not shown). Finally, we placed the lacZ
gene under the control of a 0.9 kb SmaI/NcoI genomic
fragment containing the highly conserved region (Fig. 2e).
The sequence identity of these 0.9 kb to the homologous
human sequences is 81%. No heterologous minimal promo-
ter element was added to this construct. Using this 0.9 kb
promoter construct ®ve transgenic mouse lines were gener-
ated. In four cases expression in the pancreas of E 10.5 mice
(Fig. 3D) and in islets of newborn embryos (Fig. 3E,F) was
detected. As in the wild type situation no expression was
detectable soon after birth (not shown). These data indicate
that the 0.9 kb genomic fragment contains all relevant regu-
latory elements that are suf®cient for driving the Pax4
expression in the pancreas in vivo.
2.4. Sequence motifs present in the Pax4 promoter
Within the highly conserved 407 base pair cassette we
found sequence motifs that are identical or similar to promo-
ter elements known to mediate beta cell or delta cell speci®c
expression of genes (Fig. 4, details in Section 3). One of
them is a perfectly ®tting inverted mouse insulin control
element (ICE, 5 0-GCCATCTGCT-3 0, Fig. 4a, nt. 98±107;
which had later been renamed E1 element in accordance
with the nomenclature proposed by German et al., 1995).
Another motif (5 0-CTAATG-3 0) has been shown to be
recognized by the Isl1 protein in the insulin promoter
(Karlsson et al., 1990) and can be found 43 bp downstream
of the inverted E1 element in the Pax4 promoter (Fig. 4a, nt.
141±146).
3. Discussion
The molecular dynamics of the developing pancreas
requires a complex interaction between transcription and
growth factors during maturation of pancreatic cells and
structures. An understanding of the mechanisms of differ-
entiation and proliferation during pancreas development
C. Brink et al. / Mechanisms of Development 100 (2001) 37±4340
Fig. 4. Homology between human and mouse DNA sequence within the
Pax4 promoter and location of targets for transcription factors. (a) The
human sequence is outlined in the upper, the mouse sequence is given in
the bottom row. The 407 nucleotides spanning cassette showing 88% iden-
tity between the two species is marked in red. The sequence motifs, that
have been shown to be recognized by transcription factors expressed in beta
and delta cells are marked with frames: A2(IAPP)A2 element known
from the IAPP promoter, recognized by Pdx1; E1(Ins) inverted E1
element known from the insulin promoter, recognized by a BETA2/NeuroD
containing protein complex; Isl1 (Ins) core sequence of motifs recog-
nized by Isl1 on the insulin promoter; HNF3beta(Pdx1) sequence motif
similar to a HNF3beta-recognized element of the Pdx1 promoter. Details
and references in the text. (b) Overview of the position and orientation of
the given motifs.
will be important to devise novel therapies for pancreatic
disorders. Since Pax4 is a main regulator of the develop-
ment of insulin-producing beta cells, knowledge of its
promoter regions would be essential to our understanding
of pancreas development and diseases. In this study we have
been able to isolate a genomic DNA fragment of 0.9 kb that
contains cis-regulatory elements suf®cient to mediate Pax4
expression in mice. Within this fragment we detected a
region of 407 bp showing 88% identity to the homologous
human region. Inside this highly conserved area previously
described target sequences of four transcription factors were
discovered. All of them have already been shown to parti-
cipate in beta or delta cell speci®c expression of genes.
3.1. The E1 element of the Pax4 promoter
The expression of genes responsible for endocrine
pancreas development undergoes remarkable changes
during gestation. Earliest endocrine precursor cells coex-
press numerous genes like Pax4, Pax6, Pdx1, Nkx2.2, insu-
lin and glucagon which later in development become
selectively restricted to distinct cell types of the Islets of
Langerhans (Yamaoka and Itakura, 1999). Pax4 expression
during later development is restricted to beta cells, showing
a maximum expression level at E 15.5, and is switched off at
birth (Dohrmann et al., 2000). In contrast, other genes like
Pdx1, IAPP and insulin remain or become selectively active
in beta cells. The E1 element of the insulin promoter has
been shown to be responsible for beta-cell-speci®c insulin
expression (Sharma et al., 1997). According to our sequence
analysis it can also be found within the Pax4 promoter in an
inverted orientation. The protein complex that regulates the
E1 motif of the insulin promoter is composed of tissue-
speci®c (BETA2/NeuroD), and generally distributed (E2A
and HEB encoded) gene products of the basic helix-loop-
helix (bHLH) family (Sharma et al., 1997). The mechanisms
of E1 activation mediated by the BETA2/NeuroD containing
complex have been shown to act selectively in beta cells.
However, a similar type of promoter regulation can be found
as tissue speci®c activators of the bHLH class, the best
characterized of which are the myogenic bHLH activators
(i.e. MyoD, myogenin, myf-5, and MRF-4; Bengal et al.,
1992; Li et al., 1992). Therefore, the E1 element of the
Pax4 promoter has the potential to act as a multifunctional
regulator element on Pax4 expression.
3.2. The A2 element
A 17 bp motif contacting the E1 element at the 5 0 end
contains 94% homology to the A2 element known from the
human islet amyloid polypeptide (IAPP) gene promoter
(Carty et al., 1997; Fig. 4a, nt 78±93). IAPP is exclusively
expressed in beta and delta cells (Carty et al., 1997) and has
been proposed to play an important role in regulating
plasma glucose levels in mammals (Carty et al., 1997).
The A2 element of the IAPP promoter, known to be an
activator of IAPP expression, has been shown to be a target
of Pdx1 protein (Carty et al., 1997), Pdx1 is ubiquitously
expressed in the early developing pancreas and later
becomes restricted to beta cells. Pdx1 was shown to be a
main regulator of early pancreas development and is
involved in the glucose dependent insulin response of the
mature beta cells (Yamaoka and Itakura, 1999). Since the
A2 element regulates gene expression in differentiated beta
and delta cells these ®ndings suggest that Pdx1 could be also
a candidate to in¯uence Pax4 expression in mature beta
cells.
3.3. HNF3beta and Isl1
An inverted consensus sequence that regulates Pdx1
expression by binding HNF3beta (Wu et al., 1997) shows
up further downstream (Fig. 4a, nt. 204±214). HNF3beta is
expressed in pancreatic beta cells and duct cells. The func-
tional consensus sequence recognized by HNF3beta shows
91% identity to the sequence motif present in the Pax4
locus. Hence HNF3beta represents another promising
candidate for Pax4 regulation.
Mice de®cient of Isl1 show severe defects in the devel-
opment of the pancreas and the surrounding mesenchyme
(Ahlgren et al., 1997). Therefore the Isl1 recognition site
detected in the Pax4 promoter region might be a hint for a
more general regulation of Pax4 carried out by Isl1.
3.4. Additional factors present in the developing endocrine
pancreas
The presence of binding motifs for Pdx1, BETA2/
NeuroD, Isl1 and HNF3beta protein suggests that these
genes might be involved in the regulation of the Pax4 gene.
However, all of the described regulations carried out by
these transcription factors are positive (Sharma et al., 1997;
Carty et al., 1997; Wu et al., 1997; Ahlgren et al., 1997). To
explain how the silencing of Pax4 expression at birth is
accomplished, additional genes that are expressed during
endocrine pancreas development and might act as repressors
need to be examined for their in¯uence on Pax4 expression.
The functional promoter element contains several TAAT
motifs (Fig. 4a), that might be targets for different homeo-
box genes and there might be competition of several protein
complexes for binding to the E1 motif. Neurogenin (ngn3)
regulates endocrine pancreas development (Gradwohl et al.,
2000) and is an early developmental regulator of E-box
motifs (Huang et al., 2000). It might be involved in the
control of Pax4 expression. Other genes which might play
such a role are HNF6, Hes1, Notch genes and Nkx6.1.They
have recently been shown to participate in endocrine
pancreas development or being expressed in the developing
tissue (Jacquemin et al., 2000; Jensen et al., 2000; Lammert
et al., 2000; Jensen et al., 1996). Their in¯uence on Pax4
expression will be the subject of our future experiments. In
this regard it is worthwhile to mention that Pax4 itself has
been described as a transcriptional repressor (Smith et al.,
1999). After submission of this manuscript an article has
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appeared in which an autoregulatory loop during Pax4
expression is suggested (Smith et al., 2000).
3.5. Alternative transcription initiation site
The putative Pax4 transcription start site predicted by
sequence comparison lacks the classical promoter elements.
However, the analyzed 0.9 kb promoter construct mediates
reporter gene activity without a classical minimal promoter
or the sequences surrounding the native transcription start.
Our results suggest the presence of an alternative transcrip-
tion start site within the remaining sequences of all smaller
constructs.
Taken together, our results concerning the Pax4 promoter
provide a ®rst insight into possible mechanisms of regula-
tion of this gene. Because of their expression pattern and the
presence of target sequences on the Pax4 promoter, Pdx1,
BETA2/NeuroD, HNF3beta and Isl1 appear as promising
candidates for the regulation of Pax4. Further experiments
are needed to analyze each module of the promoter for its
role in regulating Pax4 expression in vivo. It is also neces-
sary to prove if the same cis-regulatory elements, that
mediate an activation of expression in a particular promoter
(E1, A2) might act as repressors on a different promoter
within the same cell.
4. Experimental procedures
4.1. DNA constructs
For the genomic clone a 19 kb genomic mouse DNA
fragment containing the Pax4 locus was cloned into the
NotI site of the p-bluescript cloning vector provided by
Stratagene.
For the 7.8 kb construct a 11.2 kb NheI/SpeI fragment
was replaced by a 3.7 kb HindIII/BamHI-fragment out of
the Pharmacia pCH110 vector which contains the lacZ gene.
A blunt end ligation placed the lacZ gene to the third exon in
frame of the native Pax4 ATG in the second exon. The
orientation was checked by sequencing. Further constructs
have been created out of this one by cutting out NcoI (2.5
kb), SacII/BalI (1.2 kb) and AvrII (1.0 kb) fragments and
relegation.
For the 0.9 kb construct a SmaI/NcoI fragment was
cloned blunt into the SmaI site of the pbeta-Gal-basic vector
provided by Clontech. The orientation was checked by
HindIII digestion.
4.2. Transgenic mice
All lacZ-fusion gene constructs were linearized and
microinjected into the pronuclei of fertilized FVB mouse
oocytes by using standard procedures (Hogan et al.,
1994). Genomic DNAs prepared either from yolk sac or
from tail biopsies were digested with the restriction endo-
nuclease BamHI for southern blot analysis, using a labelled
lacZ probe ampli®ed by PCR out of pCH110 or pbeta-Gal-
basic to con®rm the integration of the transgene.
4.3. lacZ staining
Beta galactosidase activity of E 10.5 embryos and
newborn pancreas was determined as described in St.
Onge et al. (1997). For sections the tissue was embedded
in paraf®n after staining.
4.4. Immunohistochemistry
Primary antibodies mouse anti-insulin (Sigma) were
applied on paraf®n sections after beta-galactosidase staining
as previously described (Sosa-Pineda et al., 1997) and
detected with a red-¯uorescent secondary antibody (alexa
594).
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